Blood tests to track cancer signals after treatment
Treatments studied
Part of Cancer clinical trials.
This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient who has been treated for cancer at one of the participating study centers
- You are 18 years or older
- You can sign an informed consent form to join the study
- You are able to participate in follow-up visits and have no major issues that would prevent you from completing the study (for example, location or support problems)
- You must not be under guardianship or otherwise have your liberty restricted
- If the study team also wants a biopsy in addition to blood tests: the tumor must be accessible for biopsy, your blood clotting tests (if needed) must be normal, and you must not be taking blood thinners or antiplatelet medicines for the biopsy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a blood test that looks for circulating tumor markers in people with any type of invasive cancer (newly diagnosed or suspected). The goal is to see if markers in the blood can help monitor the cancer and guide treatment.
This study collects extra blood samples during your routine care to look for markers that might help predict how well cancer treatments work and how long people live. Participating involves no extra procedures beyond what you already need.
This trial looks at blood samples to measure substances that may reflect cancer (tumor markers). It may help doctors understand cancer better and improve future monitoring, as long as you can safely and regularly take part.
This study uses blood samples to look for tiny pieces of cancer cells called circulating tumor cells. Your results may help researchers understand how cancer cells spread and how cancer could be monitored over time.
This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.
This study collects and stores blood and protein samples from people with cancer to help future research. You may be asked to return for follow-up appointments so the researchers can link your samples to health outcomes.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.